More Globe Newswire

View Older Stories View Newer Stories

Feb 22, 2024 08:00AM ABM to Announce First Quarter 2024 Financial Results
Feb 22, 2024 08:00AM Clene Reports Significant Survival Benefit With CNM-Au8® Treatment in ALS EAP Compassionate Use Programs
Feb 22, 2024 08:00AM Apnimed to Participate in the Upcoming Evercore ISI 2024 Emerging Biotech Conference
Feb 22, 2024 08:00AM IMNN-101 Preclinical Data in SARS CoV-2 Published in Peer-Reviewed Journal Vaccine
Feb 22, 2024 08:00AM Autonomix Secures Principal Investigators and Completes Clinical Training for First Human Study
Feb 22, 2024 08:00AM DMG Blockchain Solutions Announces Investment in Digital Asset Custody Solution
Feb 22, 2024 08:00AM Tilray Brands, Owner of 5ᵗʰ Largest U.S. Craft Beer Business, Selects MicroStar Logistics as Long-Term Keg Supply Chain Partner
Feb 22, 2024 08:00AM American College of Medical Genetics and Genomics Includes OGM in Latest Edition of Technical Laboratory Standards for Solid Tumor Analysis
Feb 22, 2024 08:00AM Tarsus Announces Positive Topline Results from Carpo, a Phase 2a Proof-of-Concept “Tick-Kill” Trial Evaluating TP-05 (lotilaner) for the Prevention of Lyme Disease
Feb 22, 2024 08:00AM Soleno Therapeutics to Present at the TD Cowen 44th Annual Health Care Conference
Feb 22, 2024 08:00AM Mexican Rail Operator Renews Support Contract and Adds Duos AI
Feb 22, 2024 08:00AM La Rosa Acquires Seventh Real Estate Brokerage Franchisee with Revenue of $1.4 Million and Positive Cash Flow in 2023
Feb 22, 2024 08:00AM BioAdaptives, Inc. Announces NaturaComplete™, an All-In-One Supplement to Optimize Its AI-Based FYO Obesity Management System
Feb 22, 2024 08:00AM Comscore Transforms Local and National Ad Campaigns with Pioneering Cross-Platform Audience Measurement
Feb 22, 2024 08:00AM Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference
Feb 22, 2024 08:00AM Treasure Global and Silica-AI Forge Strategic Partnership to Revolutionize AI and IoT Landscape Across Southeast Asia
Feb 22, 2024 08:00AM Spectral Receives UKCA Authorization for Burn Indication Expected Commercialization 2nd Half 2024
Feb 22, 2024 08:00AM authID Inc. Announces Change to its Board of Directors for Next Phase of Growth
Feb 22, 2024 08:00AM Fansee Embarks on a Revolutionary Path under the Leadership of Visionary CEO Jason Hung
Feb 22, 2024 08:00AM Spectaire Announces New Demand by Canadian Trucking Fleets for Deployment of AireCore Technology in Response to Escalating Carbon Taxes
Feb 22, 2024 08:00AM Verizon Business building highly customized private 5G environment for Audi AG automotive test track
Feb 22, 2024 08:00AM Centessa Pharmaceuticals to Participate in TD Cowen’s 44th Annual Health Care Conference
Feb 22, 2024 08:00AM Talkspace Announces Fourth Quarter and Full Year 2023 Results
Feb 22, 2024 08:00AM GoHealth to Announce Fourth Quarter and Year End 2023 Results on March 14, 2024
Feb 22, 2024 08:00AM Salarius Provides Update on Strategic Review Process and Plans to Support Ongoing Seclidemstat Clinical Trials by Further Reducing Expenses
Feb 22, 2024 08:00AM Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update
Feb 22, 2024 08:00AM Addressing Obesity in the Public Sector
Feb 22, 2024 08:00AM Despite Seasonal Dip in Q4 2023, Insurance Shopping Likely to Remain Strong in 2024
Feb 22, 2024 08:00AM Pacira to Report 2023 Financial Results on Thursday February 29, 2024
Feb 22, 2024 08:00AM Medela Launches Innovative Smart Watch App for New Parents
Feb 22, 2024 08:00AM Lisata Therapeutics to Host Year-End 2023 Conference Call on Thursday, February 29, 2024 at 4:30 p.m. Eastern Time
Feb 22, 2024 08:00AM Notice of Nexstim Plc’s 2023 Full Year Results
Feb 22, 2024 07:58AM Nuwellis’ Distribution Partner, SeaStar Medical, Receives FDA Humanitarian Device Exemption for Pediatric Selective Cytopheretic Device Quelimmune™
Feb 22, 2024 07:56AM Form 8.3 - [ SHANTA GOLD LIMITED - 21 02 2024] - (CGAML)
Feb 22, 2024 07:53AM FDA Grants Humanitarian Device Exemption Approval to SeaStar Medical’s Selective Cytopheretic Device for Pediatric Acute Kidney Injury
Feb 22, 2024 07:51AM Form 8.3 - [ LONDONMETRIC PROPERTY PLC - 21 02 2024] - (CGWL)
Feb 22, 2024 07:47AM ZyVersa Therapeutics Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases, and Data Supporting Inflammasome ASC Inhibitor IC 100 as a Potential Therape
Feb 22, 2024 07:42AM Save Foods: NTwo Off Filed US Patent Application to Reduce Greenhouse Gas Emissions in Wheat Production
Feb 22, 2024 07:41AM Notification of transactions in Columbus A/S shares and related securities by persons discharging managerial responsibilities and persons closely associated with them
Feb 22, 2024 07:38AM Medigus: ParaZero Ramps Up Partnership with US-Based Autonomous Drone OEM Vayu Aerospace Corporation
Feb 22, 2024 07:35AM Incentive scheme
Feb 22, 2024 07:32AM Ocular Therapeutix Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Executive Chairman and Chief Strategy Officer
Feb 22, 2024 07:31AM Ocular Therapeutix, Inc. Announces $325.0 Million Private Placement
Feb 22, 2024 07:30AM Carnegie Clean Energy to Present at Clean/Renewable Energy Virtual Investor Conference February 22nd
Feb 22, 2024 07:31AM The Shyft Group Reports Fourth Quarter and Full-Year 2023 Results
Feb 22, 2024 07:30AM FTI Consulting Reports Record Fourth Quarter and Full Year 2023 Financial Results
Feb 22, 2024 07:30AM Highland Copper Announces Appointment of Barry O’Shea as Chief Executive Officer
Feb 22, 2024 07:30AM Intra-Cellular Therapies Reports Fourth Quarter And Full-Year 2023 Financial Results And Provides Corporate Update
Feb 22, 2024 07:30AM Ocular Therapeutix™ Announces Board of Directors and Leadership Updates
Feb 22, 2024 07:30AM Intellia Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Highlights Recent Company Progress
View Newer Stories View Older Stories